Welcome to LookChem.com Sign In|Join Free
  • or
1H-Pyrazole-4-carboxamide, 5-amino-3-methyl-1-phenyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

50427-81-1

Post Buying Request

50427-81-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

50427-81-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 50427-81-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,0,4,2 and 7 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 50427-81:
(7*5)+(6*0)+(5*4)+(4*2)+(3*7)+(2*8)+(1*1)=101
101 % 10 = 1
So 50427-81-1 is a valid CAS Registry Number.

50427-81-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-amino-3-methyl-1-phenylpyrazole-4-carboxamide

1.2 Other means of identification

Product number -
Other names 5-Amino-3-methyl-1-phenyl-1H-pyrazole-4-carboxylic acid amide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:50427-81-1 SDS

50427-81-1Relevant academic research and scientific papers

Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure–activity relationship and biological activity as potential antitumor and anticonvulsant agents

Lamie, Phoebe F.,El-Kalaawy, Asmaa M.,Abdel Latif, Noha S.,Rashed, Laila A.,Philoppes, John N.

, (2021)

A new series of pyrazolo[3,4-d]pyrimidine/triazine hybrids 6a-r was designed as antitumor and anticonvulsant agents. All the prepared compounds were evaluated against colon (HCT-116), breast (MCF-7) and normal human fibroblast (WI38) cell lines. The most

Synthesis of pyrazolopyrimidinones as sildenafil derivatives and sclerotigenin

Heo, Hoon Gu,Yu, Jin,Jillella, Raveendra,Oh, Chang Ho

supporting information, p. 1678 - 1687 (2018/06/14)

A series of novel pyrazolo pyrimidinone derivatives (3(a–d), 4(a–d), and 6(a–d)) was synthesized from various pyrazolo amides (2a–d) which are synthesized by the reaction between ethyl 5-amino-3-methyl-1-phenyl-1H-pyrazole-4-carboxylate (1) and various lithium amides. In addition, we also described the synthesis of sclerotigenin drug molecule which has quinazoline moiety from simple 2-nitro benzoic acid with high yields.

Synthesis and biological evaluation of novel pyrazolopyrimidines derivatives as anticancer and anti-5-lipoxygenase agents

Rahmouni, Ameur,Souiei, Sawssen,Belkacem, Mohamed Amine,Romdhane, Anis,Bouajila, Jalloul,Ben Jannet, Hichem

, p. 160 - 168 (2016/05/19)

A novel series of 6-Aryl-3-methyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-ones 3a-h were synthesized in a single step via condensation of carboxamide 2 with some aromatic aldehydes (presence of iodine). Treatment of aminopyrazole 1a with acetic anhydri

INDAZOLE COMPOUNDS USEFUL AS KETOHEXOKINASE INHIBITORS

-

Page/Page column 45, (2011/11/06)

The present invention is directed to substituted indazole compounds, pharmaceutical compositions of these compounds and methods of use thereof. The compounds of the present invention are ketohexokinase (KHK) inhibitors, useful for treating or ameliorating a KHK mediated metabolic disorders and/or diseases such as obesity, Type II diabetes mellitus and Metabolic Syndrome X.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 50427-81-1